GRANTS:
S.N. |
Funding Agency |
Title of Project |
Duration |
Amount |
1 |
DST-SERB (Co-PI) |
Center of Antibody Engineering: Center for Immuno-Diagnostics/ Therapeutics Veneering technologies (CIVET) Mar 2022-Mar 2025 |
3 Years |
~187 Lakhs Ongoing |
2 |
DBT (Co-PI) |
Specific single domain antibodies (sdAbs) against antimicrobial resistant Mastitis pathogens for clinical therapeutic use in dairy animals Mar 2022-Mar 2025 |
3 Years |
~59.6 Lakhs Ongoing |
3 |
STARS (MHRD) (PI) |
Designing and large scale production of recombinant single chain antibody (scFv) against human Tumor Necrosis Factor alpha (hTNF-alfa) (31-12-2019 to Feb28.-2024) |
3 Years |
48.84 Lakhs Ongoing |
4. |
DBT (PI) |
Development of a scalable expression platform for the overproduction of commercially important novel Ubiquitin-Like proteases (Ulps) from Schizosaccharomyces pombe in Escherichia coli (29-02-2020 to 28-02-2023) |
3 Years |
39.15 Lakhs Completed |
5. |
SERB (PI) |
Genome mining of Pichia pastoris for the development of yeast cell surface display technology using its native cell wall anchoring proteins: bioprocess optimization and its biotechnological applications. (26-03-2019 to 25-03-2022) |
3 Years |
39.59 Lakhs Completed |
6. |
DRDO (Co-PI) |
Process Development for enzymatic synthesis of L-theanine, a Nutraceutical, using gamma-glutamyl transpeptidase from Bacillus licheniformis (18-09-2018 to 17-09-2021) |
3 Years |
33.13 Lakhs Completed |
7. |
DBT (PI) |
Cloning Expression and Bioprocess Optimization of Recombinant human Interleukin-7 (hIL-7) in methylotrophic yeast Pichia Pastoris (16-06-2011 to 15-06-2014) |
3 Years |
30.50 Lakhs Completed |
8. |
DST (PI) |
Bioprocess optimization of human Granulocyte Macrophage Colony Stimulating Factor (hGM-CSF) expression in Escherichia coli. (04-05-2012 to 03-05-2015) |
3 Years |
25.00 Lakhs Completed |
9. |
UGC (PI) |
Bioprocess optimization of scFv Production against hGM-CSF in Methylotrophic yeast, Pichia pastoris (26-07-2012 to 25-07-2015) |
3 Years |
8.45 Lakhs Completed |
10. |
DBT(PI) |
Bioprocess development of recombinant therapeutics in Pichia pastoris: Human Interleukin-3 (hIL-3) as a model system (22-04-2013 to 21-04-2016) |
3 Years |
51.59 Lakhs Completed |